Antianginal / Heart Failure Drugs Flashcards

(95 cards)

1
Q

Isosorbide Dinitrate

A

Nitrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Isosorbide Mononitrate

A

Nitrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Available as oral

A

Isosorbide mononitrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Available as sublingual (TABLET AND SPRAY), oral, IV, transdermal patch, and topical ointment

A

Nitroglycerine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nitrate: MOA

A
  • releases nitric oxide (NO) in vascular smooth muscle
  • relaxes venous smooth muscle
  • increases coronary blood flow
  • reduces preload and BP (reflex tachycardia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nitrate: indications

A

Angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Continuous use leads to tolerance

A

Nitrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Do not use in HF

A
  • Diltiazem
  • Verapamil
    (Nondihydropyridines)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitrates: adverse effects

A
  • headache
  • dizziness
  • hypotension
  • reflex tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nitrates: interactions

A
  • 5-PDE inhibitors (contraindicated if using nitrates daily)

- do not use within 24 or 72 hours of 5-PDE inhibitors use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nitroglycerine

A

Nitrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NifeDIPINE

A

Calcium channel blocker

Dihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3A4 inhibitors

A
  • Diltiazem
  • Verapamil
    (Nondihydropyridines)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NicarDIPINE

A

Calcium channel blocker

Dihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FeloDIPINE

A

Calcium channel blocker

Dihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diltiazem

A

Calcium channel blocker

Nondihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Verapamil

A

Calcium channel blocker

Nondihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Calcium channel blockers: MOA

A
  • prevent entry of Ca into cells
  • peripheral vasodilation, decreased afterload
  • coronary vasodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Decrease mycocardial contractility, heart rate, and AV node conduction

A

Nondihydropyridine CCBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Adverse effects of all calcium channel blockers

A

Gingival hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Adverse effects of dihydropyridines

A
  • dizziness, headache
  • peripheral edema
  • reflex tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Adverse effects of nondihydropyridines

A

constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Indicated for atrial arrhythmias

A
  • Diltiazem
  • Verapamil
    (Nondihydropyridines)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

AmloDIPINE

A

Calcium channel blocker

Dihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Increases Digoxin levels
Verapamil
26
B-Blockers
- decreases heart rate and contractility therefore DECREASES OXYGEN DEMAND - INCREASES DIASTOLIC FILLING therefore better coronary perfusion increases oxygen supply
27
Selective B-blockers
Atenolol | Metoprolol
28
Nonselective B-blockers
Propranolol
29
Ranolazine
B-blocker
30
Ranolazine: pharmacokinetics
Metabolized by 3A4
31
Indicated for treatment of CHONIC ANGINA
Ranolazine
32
Should not be used w/ 3A4 inducers or strong 3A4 inhibitors
Ranolazine
33
Warning: QT prolongation (caution w/ other drugs that can cause QT prolongation
Ranolazine
34
Ranolazine: adverse effects
- constipation - dizziness - headache
35
How do we treat acute angina?
- sit or lie down - NTG under the tongue (do not swallow) - wait 5 minutes for pain releif - if no pain relief, call 911 - may repeat 2 more times
36
Definition of HF
Complex CLINICAL SYNDROME that results from any structural or functional impairment of ventricular filling or eject blood
37
Cardinal manifestations of HF
- dyspnea - fatigue - may limit exercise tolerance and fluid retention - may lead to pulmonary or splanchnic congestion and/or peripheral edema
38
When is the term "heart failure" preferred over "congestive heart failure?"
when patient presents w/o signs/symptoms of volume overload
39
Pathophysiology of heart failure
Reduction in tissue perfusion activates neurohumoral system response - Renin-angiotensin-aldosterone system (RAAS) - Sympathetic nervous system
40
Pathophysiology of heart failure: RAAS
- vasoconstriction (angiotensin II) - Angiotensin II stimulates secretion of aldosterone (causes remodeling and fibrosis) and antidiuretic hormone - Angiotensin II causes Na and water retention - Angiotensin II leads to cardiac remodeling and fibrosis
41
Pathophysiology of heart failure: SNS
- Vasoconstriction | - cardiac remodeling leading to myocyte death
42
Digoxin
Digitalis glycoside
43
Adrenergic agonists
Dobutamine
44
Phosphodiesterase inhibitor
Milrinone
45
Increase Carbamezapine levels
- Diltiazem - Verapamil (Nondihydropyridines)
46
What drugs have a positive inotropic effect?
- Digoxin - Phosphodiesterase inhibitors (Milrinone) - Dobutamine
47
What drugs have a negative inotropic effect?
- Diltiazem - Verapamil (Nondihydropyridines) DO NOT USE IN HEART FAILURE
48
Positive inotropic definition
Increase cardiac CONTRACTILITY
49
Digoxin antidote
Digoxin immune Fab
50
Digoxin: pharmacokinetics
- Renally excreted | - Very low therapeutic index (monitor for toxicity)
51
Indicated for HF (reduces morbidity but NOT MORTALITY) and Atrial Fib
Digoxin
52
Blurred vision, yellow, green, or blue colors
Digoxin
53
Adverse effect includes anorexia, N&V
Digoxin
54
Adverse effect includes arrhythmias (most common AV block)
Digoxin
55
Digoxin MOA/pharmacologic effect
HF: POSITIVE INOTROPIC and NEGATIVE CHRONOTROPIC AND DROMOTROPIC EFFECT - inhibits Na pump and increases intracellular Na causing more Ca to enter the myocyte, thus INCREASING CONTRACTILITY Atrial Fib: INCREASES PARASYMPATHETIC TONE and REDUCES SYMPATHETIC TONE - slows heart rate - slows AV node conduction velocity
56
Can cause seizures
Digoxin
57
Amiodarone Propafenone Verpamil and diltiazem
can increase Digoxin serum levels
58
Used for short term management of acute HF and cardiogenic shock
Dobutamine
59
Aluminum and Magnesium containing antacids | Cholestyramine/Colestipol
can decrease Digoxin serum levels
60
Precipitate Digoxin toxicity by enhancing pharmacodynamics effects
Diuretic induced hypokalemia
61
Can also cause ventricular arrhythmias and hypokalemia can precipitate arrhythmias
Digoxin
62
Dobutamine adverse reactions
- tachycardia | - arrhythmias
63
Milrinone indication
Short term management of acute HF (usually less than 48 hours)
64
Inhibits type III phosphodiesterase
Milrinone
65
Milrinone MOA
increases cardiac contractility and relax vascular smooth muscle (vasodilation) by inhibiting type III phospodiesterase
66
Nesiritide adverse effects
- Hypotension | - Renal impairment
67
Nesiritide
Vasodilator
68
Form of human b-type natriuretic peptide; causes vasodilation of vascular smooth muscle and vasodilation
Nesiritide
69
Indicated for acute DECOMPENSATED HF
Nesiritide
70
Dobutamine MOA
increases cardiac contractility and hear rate, small effect of preload and decreased afterload
71
Shown to decrease morbidity and mortality in HF patients
ACEI
72
Contraindicated in patients w/ a systolic blood pressure of less than 90 mm Hg
Nesiritide
73
ACEI w/ NSAIDs
Decreases effect of ACEI and may result in decreased renal function, hyperkalemia
74
ACEI w/ Lithium
increases lithium levels (leads to toxicity)
75
Thiazolidinediones (Rosiglitazone and Pioglitazone)
Should generally be avoided in patients w/ HF
76
Valsartan
Angiotensin II Receptor Blocker (ARB)
77
ACEI w/ Spironolactone, Eplerenone, Potassium supplements, ARBs, Trimethoprim
Increase potassium levels (hyperkalemia)
78
What should be considered in patients who are intolerant to ACEI such as cough (do not inhibit bradykinin)?
ARBs
79
When should you use caution when using ARBs?
In people who have developed angioedema while on ACEI.
80
ARB drug interactions
same as ACEI drug interactions
81
Hydralazine/Isosorbide Dinitrate
Vasodilator
82
What does isosorbide do?
relaxes VENOUS smooth muscle
83
When may you use Hydralazine and Isosorbide Dinitrate (Nitrates)?
if intolerante to ACEIs or ARBs; can be used as an alternative
84
What does hydralazine do?
relaxes ARTERIAL smooth muscle
85
Candesartan
Angiotensin II Receptor Blocker (ARB)
86
Indicated in African Americans on optimal therapy w/ ACEIs, B-blockers, and diuretics.
Hydralazine and Isosorbide Dinitrate
87
What do B-blockers do?
Reduce excessive sympathetic stimulation of the heart - sympathetic activation also increases activation of RAAS - chronic stimulation of sympathetic nervous system leads to hypertrophy and apoptosis - increases cytokines REDUCES MORTALITY AND MORBIDITY
88
B-blockers and NSAIDs
decrease effect of B-blockers
89
Metformin
Should generally be avoided in patients w/ HF (in "acute congestive heart failure")
90
Effects on morbidity and mortality are not known
Loop diuretics
91
Antiarrhythmics (except Amiodarone)
Should generally be avoided in patients w/ HF
92
Non-DHP CCBs
Should generally be avoided in patients w/ HF
93
NSAIDs and COX2 inhibitors
Should generally be avoided in patients w/ HF
94
Nondihydropyridines: Indications
- HTN - Angina - Atrial arrhythmias
95
Strong 3A4 inhibitor/s (e.g. Azole antifungals and clarithromycin) increase levels of...
calcium channel blockers (Dihydropyridines and Nondihydropyridines)